Supriya Lifescience IPO GMP, Price, Date, Allotment

0

Last updated on December 28, 2021

Supriya Lifescience IPO GMP

Supriya Lifescience IPO description – The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with focus on research and development. As of 31 October 2021, it had niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India, between Fiscal 2017 and 2021. It was among the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms.

Its pharmaceutical business is organized into domestic and export sales. From 1 April 2020 until 31 October 2021, its products were exported to 86 countries to 1,296 customers including 346 distributors.  Its customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda, with whom we have business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom it has business relationship for over four years.

Supriya Lifescience’s business operations are supported by a manufacturing facility located in Parshuram Lote, Maharashtra, which is approximately 250 km from Mumbai, Maharashtra. The manufacturing facility is spread across 23,806 sq. mts, having reactor capacity of 547 KL/ day and seven cleanrooms. In addition, the company has acquired a plot of land, admeasuring 12,551 sq.mt, near the present manufacturing facility, wherein it intends to expand its manufacturing infrastructure.

Promoters of Supriya Lifescience Limited – Satish Waman Wagh


Supriya Lifescience IPO Details

Subscription Dates16 – 20 December 2021
Price BandINR265 – 274 per share
Fresh issueINR200 crore
Offer For Sale INR500 crore
Total IPO size INR700 crore
Minimum bid (lot size)54 shares
Face Value INR 2 per share
Retail Allocation10%
Listing OnNSE, BSE

Supriya Lifescience’s Financial Performance

 FY2019FY2020FY2021H1 FY2022
Revenue285.9322.7396.2230.1
Expenses213.1213.3218.1131.4
Net income39.473.4123.866.0
Margin (%)13.822.731.228.7
Figures in INR crore unless specified otherwise

Supriya Lifescience IPO News


Supriya Lifescience Valuations & Margins

FY2019FY2020FY2021
EPS5.3910.0316.92
PE ratio15.66 – 16.19
RONW (%)42.0349.2046.04
ROCE (%)
EBITDA (%)25.4533.9244.96
Debt/Equity0.940.550.26
NAV36.75

Supriya Lifescience IPO GMP Daily Trend

Date Supriya Lifescience IPO GMPKostakSubject to Sauda
27 Dec 2021INR150INR200INR4,000
25 Dec 2021INR130INR200INR4,000
24 Dec 2021INR150INR200INR4,000
23 Dec 2021 INR120INR200INR3,500
22 Dec 2021INR100INR150INR3,000
21 Dec 2021 INR130INR150INR3,500
20 Dec 2021 INR150INR150INR3,500
18 Dec 2021 INR250INR200INR4,000
17 Dec 2021 INR220INR200INR3,800
16 Dec 2021 INR250INR250INR3,800
15 Dec 2021INR250INR300INR4,000
14 Dec 2021 INR250

Supriya Lifescience IPO Subscription – Live Updates

CategoryShares OfferedDay 1Day 2Day 3
QIB79,24,5270.000.5331.83
NII39,62,2630.662.90161.22
Retail26,41,50911.8425.3855.75
Total1,45,28,2992.335.6971.47
Subscription figures in number of times, at 5 PM

Supriya Lifescience IPO Reviews – Subscribe or Avoid?

Angel One – Subscribe
Anand Rathi – Subscribe for long term
Antique Stock Broking –
Arihant Capital –
Ashika Research – Subscribe
Asit C Mehta –
BP Wealth – Subscribe
Canara Bank Securities – Subscribe
Choice Broking – Subscribe
Elite Wealth – Subscribe
GEPL Capital –
Hem Securities – Subscribe
ICICIdirect – Unrated
KR Choksey –
Marwadi Financial Services – Subscribe
Motilal Oswal – Subscribe
Nirmal Bang – Subscribe
Religare Broking –
Samco Securities – Subscribe
SMC Global – 2.5/5
Ventura Securities – Subscribe


Supriya Lifescience Offer Registrar

Link Intime India Private Limited 
C-101, 1st Floor,
247 Park Lal Bahadur Shastri Marg,
Vikhroli (West) Mumbai – 400 083
Phone: +91 22 4918 6200
Fax: +91 22 4918 6195
Email: [email protected]
Website: http://www.linkintime.co.in


Supriya Lifescience Contact Details

Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon – East,
Mumbai – 400063, Maharashtra
Phone: +91 22-40332727
Email: [email protected]
Website: www.supriyalifescience.com


Supriya Lifescience IPO Allotment Status

Supriya Lifescience IPO allotment is now available on Link Intime’s website. Click on this link to get allotment status.


Supriya Lifescience IPO Timetable

IPO Opening Date 16 December 2021
IPO Closing Date 20 December 2021
Finalisation of Basis of Allotment 23 December 2021
Initiation of refunds 24 December 2021
Transfer of shares to demat accounts 27 December 2021
Listing Date 28 December 2021
Opening Price on NSEINR421 per share (up 53.65% from IPO price)
Closing Price on NSEINR389.7 per share (up 42.23% from IPO price)

Supriya Lifescience IPO FAQs

How many shares in Supriya Lifescience IPO are reserved for HNIs and retail investors?

The investors’ portion for QIB – 75%, NII – 15%, and Retail – 10%.

How to apply in Supriya Lifescience Public Offer?

The best way to apply in Supriya Lifescience IPO is through Internet banking ASBA (know all about ASBA here). You can also apply online through your stock broker using UPI. If you prefer to make paper applications, fill up an offline IPO form and deposit the same to your broker.

What is Supriya Lifescience IPO GMP today?

Supriya Lifescience IPO GMP today is INR150 per share.

What is Supriya Lifescience IPO kostak rate today?

Supriya Lifescience IPO kostak rate today is INR200 per application.

What is Supriya Lifescience Subject to Sauda rate today?

Supriya Lifescience Subject to Sauda rate today is INR4,000 per application.

LEAVE A REPLY

Please enter your comment!
Please enter your name here